Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
Drug Transporter (DT) Information
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0270 | ||||
| Gene Name | SLC30A10 | ||||
| Protein Name | Zinc transporter 10 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
|
||||
| Synonyms | HMDPC; HMNDYT1; Manganese transporter SLC30A10; SLC30A10; Solute carrier family 30 member 10; ZNT10; ZnT-10 | ||||
| DT Family | Cation Diffusion Facilitator (CDF) Family ; | ||||
| Tissue Specificity | Specifically expressed in fetal liver andfetal brain (PubMed:15154973). Expressed in adult tissues withrelative levels small intestine > liver > testes > brain > ovary >colon > cervix > prostate > placenta (PubMed:22706290). | ||||
| Function | This transporter mediates the effux of manganese and confers protection against manganese-induced cell death, plays a pivotal role in manganese transport. Also acts as zinc transporter involved in zinc homeostasis. Seems to mediate zinc transport into early endosomes and recycling endosomes to prevent zinc toxicity; the function may be regulated by heterodimerization with other zinc transporters of the SLC30A subfamily. May be involved in regulation of zinc-dependent senescence of vascular smooth muscle cells. | ||||
| Endogenous Substrate(s) | Zn2+ | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(α) Microbiota Influence of This DT |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Zinc salts
|
Preclinical | Drug Info | Arthritis | FA5Z | [1] |
| References | |||||
| 1 | Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. Am J Hum Genet. 2012 Mar 9;90(3):467-77. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.